Antiphospholipid antibodies and reproductive failure

Human Reproduction

Volumn 15, Issue 7, 2000, Pages 1649-1650

  Stern, C ^a   Baker, G ^b   Chamley, L W ^c  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; CLINICAL TRIAL; FERTILIZATION IN VITRO; GENETIC VARIABILITY; HUMAN; INFERTILITY; LETTER; PREGNANCY RATE; REPRODUCTION; TREATMENT FAILURE;

EID: 0033806996     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.7.1649     Document Type: Letter

References (12)

1. Incidence of autoimmune antibodies in failed embryo transfer cycles
2. Antiphospholipid antibodies in pregnancy
3. Antiphospholipid antibodies in women having in-vitro fertilization
4. 2 glycoprotein I is the antigen for anticardiolipin autoantibodies
5. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction
6. Multiples of the median: An alternative method for reporting antiphospholipid antibodies in women with recurrent pregnancy loss
7. Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans
8. Characterisation of antiphospholipid antibodies in women with recurrent spontaneous abortions
9. Antiphospholipid antibodies in pregnancy: Prevalence and clinical associations
10. Genetic diversity among selected ethnic subpopulations of Australia: Evidence from three highly polymorphic DNA loci
11. 2 glycoprotein 1 in the absence of phospholipid
12. 2 glycoprotein I are significantly associated with in-vitro-fertilisation implantation failure as well as recurrent miscarriage: Results of a prospective prevalence study